Ionis Pharmaceuticals (IONS) Deferred Taxes (2018 - 2020)
Historic Deferred Taxes for Ionis Pharmaceuticals (IONS) over the last 3 years, with Q4 2020 value amounting to $340.1 million.
- Ionis Pharmaceuticals' Deferred Taxes rose 1075413.53% to $340.1 million in Q4 2020 from the same period last year, while for Sep 2021 it was $340.1 million, marking a year-over-year increase of 2214018.15%. This contributed to the annual value of $341.7 million for FY2020, which is 3741141.6% up from last year.
- According to the latest figures from Q4 2020, Ionis Pharmaceuticals' Deferred Taxes is $340.1 million, which was up 1075413.53% from $1.5 million recorded in Q3 2020.
- In the past 5 years, Ionis Pharmaceuticals' Deferred Taxes registered a high of $340.1 million during Q4 2020, and its lowest value of -$290.5 million during Q4 2018.
- Moreover, its 3-year median value for Deferred Taxes was $887000.0 (2019), whereas its average is $5.8 million.
- Within the past 5 years, the most significant YoY rise in Ionis Pharmaceuticals' Deferred Taxes was 1075413.53% (2020), while the steepest drop was 11688.69% (2020).
- Quarter analysis of 3 years shows Ionis Pharmaceuticals' Deferred Taxes stood at -$290.5 million in 2018, then skyrocketed by 98.9% to -$3.2 million in 2019, then soared by 10754.14% to $340.1 million in 2020.
- Its Deferred Taxes was $340.1 million in Q4 2020, compared to $1.5 million in Q3 2020 and $2.5 million in Q2 2020.